CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market sale See Remarks sold 442 shares at $19.13 ($8,455)
- 4 Open-market sale See Remarks sold 499 shares at $20.45 ($10,205)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Open-market sale See Remarks sold 457 shares at $19.54 ($8,930)
- 4 Open-market sale See Remarks sold 159,177 shares at $16.00 ($2,546,832)
- 4 Conversion Director acquired 18,718 shares (conversion)
- 4 Conversion Director acquired 61,657 shares (conversion)
- 4 Shares withheld for taxes See Remarks gave up 38,353 shares (to pay taxes)
- 4 Open-market sale Director sold 246,720 shares at $16.00 ($3,947,520)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 20 · 384 filings